Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.

Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.

Intestine microbiota is more and more acknowledged as the important thing participant within the pathogenesis of non-alcoholic fatty liver illness (NAFLD) by translocation of its merchandise, resembling lipopolysaccharide (LPS), through the dysfunctional intestinal barrier. Qushi Huayu decoction (QHD), a standard Chinese language medication, is developed specifically for NAFLD and utilized in clinic in China...